FACT.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research report titled “Liver Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been added to the wide online database of FACT.MR which discusses the present as well as future market scenario. Readers can access knowledge related to market volume, regional expanse as well as competitive landscape prevailing in the global liver cancer diagnostics market. In order to study development patterns, this smart assessment also focuses on market dynamics, which talks about drivers, restraints and opportunities estimated to influence the concerned market during the period until 2017 to 2022.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=73
Takeaways from the Global Liver Cancer Diagnostics Market
1- In terms of revenues, North America will remain the most lucrative region in the global market for liver cancer diagnostics. In addition, liver cancer diagnostics markets in North America and Europe will exhibit expansion at similar CAGRs through 2022.
2- Liver cancer diagnostics markets in Japan and MEA will exhibit a sluggish growth during the forecast period.
3- Biopsy tests will continue to exhibit the highest CAGR through 2022, among test type in the global market, followed by LFTs.
4- AFP test is projected to remain sought-after for liver cancer diagnostics over the forecast period. Revenues from AFP tests are estimated to hold more than half market share in 2017, and are expected to attain 52 BPS in their market share by 2022-end.
5- Hospital-associated labs are expected to remain sought-after in the market for liver cancer diagnostics. Liver cancer diagnostics in the hospital-associated labs are expected to account for largest revenues during the forecast period.
6- Independent diagnostic laboratories will continue to be the second most lucrative segment among end-users in the global market for liver cancer diagnostics.
7- Diagnosis of liver cancer in cancer research institutes will continue to register the highest CAGR over the forecast period.
8- The report has also profiled companies that will remain active in expansion of global liver cancer diagnostics market through 2022. These include Illumina, Inc.
Sysmex Corporation, Danaher Corporation, Biocept, Inc., and Foundation Medicine, Inc.
Browse Full Report With TOC- https://www.factmr.com/report/73/liver-cancer-diagnostics-market